Keyword: Bayer

News

Bayer Reports Successful 2012, Q1 2013

27.04.2013 - Last year was operationally very successful for the Bayer Group. All three subgroups achieved sales gains and raised underlying earnings. So that the stockholders benefit from this...

News

Actavis to Sell Generic Yaz Birth Control After Ruling

17.04.2013 - Pharmaceutical company Actavis said on Tuesday that it would once again sell a generic version of Bayer's Yaz after an appeals court ruled that Bayer's patent for the oral...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...

News

Brenntag Schweizerhall Teaming with Bayer CropScience and Swiss Infrapark Baselland

08.04.2013 - Brenntag Schweizerhall, the chemical distributor's Swiss subsidiary, is pleased to announce a co-operation with Bayer CropScience and Infrapark Baselland. Brenntag will invest into...

News

Clariant Acquires Nano-Silver Ink Technology from Bayer

02.04.2013 - Swiss specialty chemicals group Clariant International acquired the nano-silver ink technology platform developed under the trademark Bayink from Bayer (Germany). The transaction...

News

Novartis Loses Landmark India Cancer Drug Patent Case

02.04.2013 - India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...

News

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

27.03.2013 - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...

News

Steilemann Appointed Head of Bayer Polycarbonates Business Unit

27.03.2013 - Bayer has appointed Dr. Markus Steilemann (42) as the new head of its Polycarbonates business unit. He succeeds Michael Koenig, who will join the Board of Management of Bayer on...